Patent · US Expired

Combination therapy for osteoporosis

US6323232A · kind A · utility

12Cited by
3References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 11, 1998
Grant dateNov 27, 2001
Priority date—
Expiry dateAug 11, 2018

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S435/975
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Pharmaceutical combination compositions including certain estrogen agonists/antagonists and prostaglandins or prostaglandin agonists/antagonists. The compositions are useful for the treatment of bone disorders including osteoporosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.